Advaita Bioinformatics was founded in 2005 as a spin-off from Wayne State University. The company’s mission is to enable a true personalized medicine approach by providing advanced tools that can leverage omics and genomics data to improve drug development and patient care. The company’s expertise in big data, AI and machine learning has led to the development of IP related to: i) the identification of mechanisms of action from omics data, ii) the integration of multiple types of data and iii) the unsupervised discovery of patient subgroups and disease subtypes. These technologies, available either as SaaS or concierge services, can be used to improve the success of clinical trials by distinguishing between respondents and non-respondents, design optimal treatments by distinguishing between more and less aggressive types of diseases, repurpose drugs based and predict side-effects. Over 14,000 researchers from all over the world are currently using the Advaita’s SaaS platform.
Sorin Draghici is the founder and CEO of Advaita Bio, a spinout of his research lab at Wayne State University. He is also an associate dean for Innovation and Entrepreneurship, and director, James and Patricia Anderson Engineering Ventures Institute in the College of Engineering at Wayne State University. He currently holds the Robert J. Sokol, MD Endowed Chair in Systems Biology, as well as appointments as full professor in the Departments of Computer Science and Obstetrics and Gynecology. His work is focused on research in artificial intelligence, machine learning and data mining techniques applied to bioinformatics and computational biology, area in which he holds several patents. He has published over 150 peer-reviewed journal and conference publications as well as 8 book chapters and two books. To date, his work has gathered over 10,000 Google Scholar citations. Over 14,000 researchers from all over the world are currently using the Advaita’s platform.